Balaxi Pharmaceuticals Ltd Half Yearly Results

Gross Sales

149.56

143

120.62

120.68

167.26

Excise Duty

0

0

0

0

0

Net Sales

149.56

143

120.62

120.68

167.26

Other Operating Income

0

0

0

0

0

Other Income

2.24

-5.96

-7.56

4.92

-4.79

Total Income

151.8

137.04

113.05

125.59

162.48

Total Expenditure

133.02

122.33

46.82

147.74

139.23

PBIDT

18.78

14.71

66.23

-22.15

23.25

Interest

2.11

0.82

1.02

0.66

0.28

PBDT

16.67

13.89

65.21

-22.8

22.97

Depreciation

0.94

0.95

1.15

0.95

1.37

Minority Interest Before NP

0

0

0

0

0

Tax

1.79

1.91

1.34

3.17

4.2

Deferred Tax

-0.06

-0.04

-0.1

-0.01

1.07

Reported Profit After Tax

14

11.07

62.82

-26.91

16.33

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

14

11.07

62.82

-26.91

16.33

Extra-ordinary Items

0

0

41.02

-37.85

0

Adjusted Profit After Extra-ordinary item

14

11.07

21.8

10.94

16.33

EPS (Unit Curr.)

12.68

2.01

57.65

-26.33

16.04

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

11.04

11.04

10.9

10.23

10

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

12.55

10.28

54.9

-18.35

13.9

PBDTM(%)

-

-

-

-

-

PATM(%)

9.36

7.74

52.08

-22.29

9.76